[go: up one dir, main page]

DK1189912T3 - Nye krystallinske former af et makrolid antibiotikum - Google Patents

Nye krystallinske former af et makrolid antibiotikum

Info

Publication number
DK1189912T3
DK1189912T3 DK00914336T DK00914336T DK1189912T3 DK 1189912 T3 DK1189912 T3 DK 1189912T3 DK 00914336 T DK00914336 T DK 00914336T DK 00914336 T DK00914336 T DK 00914336T DK 1189912 T3 DK1189912 T3 DK 1189912T3
Authority
DK
Denmark
Prior art keywords
crystalline forms
new crystalline
macrolide antibiotic
macrolide
antibiotic
Prior art date
Application number
DK00914336T
Other languages
English (en)
Inventor
Robert John Rafka
Douglas John Meldrum Allen
Colman Brendan Ragan
Barry James Morton
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1189912T3 publication Critical patent/DK1189912T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00914336T 1999-05-18 2000-04-14 Nye krystallinske former af et makrolid antibiotikum DK1189912T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18
PCT/IB2000/000463 WO2000069874A1 (en) 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic

Publications (1)

Publication Number Publication Date
DK1189912T3 true DK1189912T3 (da) 2008-06-30

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00914336T DK1189912T3 (da) 1999-05-18 2000-04-14 Nye krystallinske former af et makrolid antibiotikum

Country Status (43)

Country Link
US (1) US6583274B1 (da)
EP (1) EP1189912B1 (da)
JP (1) JP3897983B2 (da)
KR (1) KR100474229B1 (da)
CN (1) CN1203084C (da)
AP (1) AP2001002325A0 (da)
AR (1) AR020030A1 (da)
AT (1) ATE392427T1 (da)
AU (1) AU772283B2 (da)
BG (1) BG106150A (da)
BR (1) BR0011300A (da)
CA (1) CA2372206C (da)
CZ (1) CZ20014120A3 (da)
DE (1) DE60038610T2 (da)
DK (1) DK1189912T3 (da)
DZ (1) DZ3043A1 (da)
EA (1) EA003417B1 (da)
ES (1) ES2302689T3 (da)
GT (1) GT200000072A (da)
HK (1) HK1045521B (da)
HN (1) HN2000000056A (da)
HR (1) HRP20010849A2 (da)
HU (1) HUP0201341A3 (da)
IL (2) IL145946A0 (da)
IS (1) IS6127A (da)
MA (1) MA26735A1 (da)
MX (1) MXPA01011914A (da)
MY (1) MY133397A (da)
NO (1) NO320195B1 (da)
NZ (1) NZ514765A (da)
OA (1) OA11876A (da)
PA (1) PA8495001A1 (da)
PE (1) PE20010151A1 (da)
PL (1) PL353316A1 (da)
PT (1) PT1189912E (da)
SK (1) SK16472001A3 (da)
TN (1) TNSN00103A1 (da)
TW (1) TWI225066B (da)
UA (1) UA67842C2 (da)
UY (1) UY26144A1 (da)
WO (1) WO2000069874A1 (da)
YU (1) YU76601A (da)
ZA (1) ZA200109420B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
DE60003586T2 (de) 2000-01-27 2004-01-08 Pfizer Products Inc., Groton Antibiotische azalid-zusammensetzungen
EP1383780A1 (en) * 2001-04-27 2004-01-28 Pfizer Products Inc. Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
CA2748847A1 (en) * 2009-01-30 2010-08-05 Glaxo Group Limited Anti-inflammatory macrolide
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
BG106150A (bg) 2002-05-31
PE20010151A1 (es) 2001-02-08
CN1351607A (zh) 2002-05-29
SK16472001A3 (sk) 2003-02-04
WO2000069874A1 (en) 2000-11-23
ES2302689T3 (es) 2008-08-01
EP1189912A1 (en) 2002-03-27
AP2001002325A0 (en) 2001-12-31
HUP0201341A3 (en) 2003-03-28
US6583274B1 (en) 2003-06-24
CA2372206C (en) 2006-01-10
HUP0201341A2 (en) 2002-08-28
NZ514765A (en) 2004-05-28
DE60038610T2 (de) 2009-06-25
IL145946A (en) 2007-06-17
TNSN00103A1 (fr) 2005-11-10
UY26144A1 (es) 2000-12-29
TWI225066B (en) 2004-12-11
JP3897983B2 (ja) 2007-03-28
PT1189912E (pt) 2008-05-16
MXPA01011914A (es) 2002-05-06
MY133397A (en) 2007-11-30
JP2002544283A (ja) 2002-12-24
PA8495001A1 (es) 2002-02-21
HN2000000056A (es) 2001-02-02
NO320195B1 (no) 2005-11-14
UA67842C2 (uk) 2004-07-15
EA003417B1 (ru) 2003-04-24
DE60038610D1 (de) 2008-05-29
CN1203084C (zh) 2005-05-25
YU76601A (sh) 2004-09-03
OA11876A (en) 2006-03-27
CZ20014120A3 (cs) 2003-01-15
PL353316A1 (en) 2003-11-17
EA200100984A1 (ru) 2002-06-27
NO20015598L (no) 2002-01-08
AU772283B2 (en) 2004-04-22
IL145946A0 (en) 2002-07-25
AU3572900A (en) 2000-12-05
DZ3043A1 (fr) 2004-03-27
KR20020007415A (ko) 2002-01-26
AR020030A1 (es) 2002-03-27
GT200000072A (es) 2001-11-08
IS6127A (is) 2001-10-26
ZA200109420B (en) 2002-11-15
KR100474229B1 (ko) 2005-03-08
HRP20010849A2 (en) 2003-04-30
ATE392427T1 (de) 2008-05-15
HK1045521B (zh) 2005-12-09
BR0011300A (pt) 2002-02-26
MA26735A1 (fr) 2004-12-20
CA2372206A1 (en) 2000-11-23
NO20015598D0 (no) 2001-11-16
HK1045521A1 (en) 2002-11-29
EP1189912B1 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
ATE345350T1 (de) Makrolidantibiotika
DK1064942T3 (da) Sustained release-fremstilling af et makrolid
NO20020814D0 (no) Nye spiroforbindelser
NO20003347L (no) Nye makrolider
NO20003346D0 (no) Nye erytromycinderivater
EE200300575A (et) Asitromütsiini kristalsed vormid
NO20012155D0 (no) Nye makrolid-antibiotika
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
NO20020810D0 (no) Nye fenylpiperaziner
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
DK1189912T3 (da) Nye krystallinske former af et makrolid antibiotikum
NO20020030L (no) Krystallinske 1-metylkarbapenemforbindelser
NO20014362L (no) Erytromycinderivater
EE05547B1 (et) Kristalliline efavirens
DK1280803T3 (da) Krystallinsk form II af cabergolin
IS6215A (is) Að mestu leyti kristallað form af melagatrani
DK1311296T3 (da) Oplösning af et antibiotisk oxazolidinon-lægemiddel
IS5821A (is) Kristalluð form af ósanetant
ID26418A (id) METODA KRISTALISASI ANTIBIOTIK β-LAKTAM
DK1246827T3 (da) Nye polymorfe former af olanzapin
NO20013601D0 (no) Nye morfolinobenzamidsalter
NO20024679L (no) Krystallinsk farmasöytikum
NO20030416D0 (no) Krystallinsk terapeutisk forbindelse
DK1228078T3 (da) Fremstilling af en makrocyklisk lakton
NO20031275D0 (no) Prodruger av et 7-acylamino-3-heteroaryltio-3-cefem- karboksylsyreantibiotika